BROOKTREE CAPITAL MANAGEMENT - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.

Quarter-by-quarter ownership
BROOKTREE CAPITAL MANAGEMENT ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,967,493
+158.4%
119,242
-1.0%
1.64%
+183.8%
Q2 2023$761,295
+91.9%
120,458
+3.1%
0.58%
+87.4%
Q1 2023$396,753
+66.3%
116,864
+183.2%
0.31%
+57.7%
Q4 2022$238,529
-73.7%
41,268
-57.2%
0.20%
-73.8%
Q3 2022$907,000
+19.5%
96,520
+183.6%
0.75%
+31.1%
Q2 2022$759,000
-26.0%
34,034
+82.6%
0.57%
-14.7%
Q1 2022$1,025,00018,6410.67%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 4,488,972$640,891,00035.51%
Antipodean Advisors LLC 656,000$93,657,00026.30%
KPS Global Asset Management UK Ltd 1,021,830$145,887,00021.39%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 302,700$43,216,00017.58%
Oakcliff Capital Partners, LP 269,895$38,533,00015.30%
Alua Capital Management LP 920,259$131,385,0009.19%
Covey Capital Advisors, LLC 47,736$6,815,0005.95%
EVR Research LP 50,000$7,139,0005.83%
683 Capital Management, LLC 659,997$94,228,0004.46%
Hidden Lake Asset Management LP 72,900$10,408,0004.08%
View complete list of CARDLYTICS INC shareholders